RDNT
RadNet, Inc. NASDAQ$59.02
Mkt Cap $4.6B
52w Low $50.76
23.5% of range
52w High $85.84
50d MA $60.69
200d MA $69.48
P/E (TTM)
-227.4x
EV/EBITDA
26.6x
P/B
3.1x
Debt/Equity
1.7x
ROE
-1.7%
P/FCF
62.7x
RSI (14)
—
ATR (14)
—
Beta
1.53
50d MA
$60.69
200d MA
$69.48
Avg Volume
845.4K
About
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and se…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | AMC | 0.19 | 0.23 | +21.1% | 75.22 | -3.0% | -3.5% | -5.2% | -11.4% | -19.3% | -17.1% | — |
| Nov 9, 2025 | AMC | 0.22 | 0.20 | -10.3% | — | — | — | — | — | — | — | — |
| Aug 10, 2025 | AMC | 0.17 | 0.31 | +82.4% | — | — | — | — | — | — | — | — |
| May 11, 2025 | AMC | -0.17 | -0.35 | -105.9% | — | — | — | — | — | — | — | — |
| Feb 27, 2025 | AMC | 0.21 | 0.22 | +4.8% | 57.60 | -13.2% | -3.7% | -11.7% | -10.0% | -7.8% | -10.5% | — |
| Nov 10, 2024 | AMC | 0.14 | 0.18 | +32.5% | — | — | — | — | — | — | — | — |
| Aug 7, 2024 | AMC | 0.16 | 0.16 | +0.0% | 56.89 | +1.5% | +8.4% | +10.4% | +8.3% | +11.2% | +10.1% | — |
| May 8, 2024 | AMC | -0.09 | 0.07 | +177.8% | 50.63 | +0.8% | +5.8% | +9.1% | +10.1% | +12.0% | +15.0% | — |
| Feb 29, 2024 | AMC | 0.11 | 0.20 | +81.8% | 37.86 | +5.7% | +17.1% | +23.7% | +25.3% | +28.1% | +28.2% | — |
| Nov 8, 2023 | AMC | 0.06 | 0.14 | +133.3% | 28.72 | +3.3% | +2.6% | +1.6% | +0.3% | +10.1% | +12.7% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 21 | Barclays | Maintains | Overweight → Overweight | — | $57.85 | $57.83 | -0.0% | -0.6% | -0.0% | -2.4% | -0.4% | -0.2% |
| Dec 1 | B. Riley Securities | Maintains | Buy → Buy | — | $82.79 | $82.25 | -0.7% | -3.4% | -4.8% | -4.0% | -2.1% | -5.1% |
| Nov 13 | Barclays | Maintains | Overweight → Overweight | — | $74.45 | $74.05 | -0.5% | -1.3% | +0.9% | +3.5% | +6.3% | +7.8% |
| Nov 12 | Truist | Maintains | Buy → Buy | — | $78.50 | $78.45 | -0.1% | -5.2% | -6.4% | -4.3% | -1.9% | +0.8% |
| Sep 3 | Barclays | Maintains | Overweight → Overweight | — | $70.31 | $71.44 | +1.6% | +0.9% | +2.8% | +1.6% | +2.4% | +3.9% |
| Sep 3 | Truist | Maintains | Buy → Buy | — | $70.31 | $71.44 | +1.6% | +0.9% | +2.8% | +1.6% | +2.4% | +3.9% |
| Aug 13 | Raymond James | Maintains | Strong Buy → Strong Buy | — | $63.60 | $64.45 | +1.3% | +7.6% | +8.1% | +6.1% | +4.2% | +6.8% |
| Apr 11 | Truist | Maintains | Buy → Buy | — | $53.00 | $52.75 | -0.5% | +0.8% | +0.7% | +0.2% | -4.7% | -6.1% |
| Mar 24 | Barclays | Maintains | Overweight → Overweight | — | $49.25 | $49.52 | +0.5% | +5.2% | +2.9% | +3.0% | +2.9% | +0.4% |
| Mar 5 | Raymond James | Upgrade | Outperform → Strong Buy | — | $51.83 | $52.25 | +0.8% | +2.4% | -0.5% | -2.9% | -7.3% | -5.0% |
Recent Filings
8-K · 7.01
! Medium
RadNet, Inc. -- 8-K 7.01: Regulation FD Disclosure
RadNet acquired French AI medical imaging company Gleamer for approximately €230 million through its subsidiary, expanding its diagnostic capabilities internationally.
Mar 2
8-K
RadNet, Inc. -- 8-K Filing
RadNet reported strong fourth-quarter 2025 results across its 418 imaging centers, with management expressing satisfaction with operational performance and positioning for continued growth.
Mar 2
Data updated apr 26, 2026 10:14pm
· Source: massive.com